Treating head and neck cancer in the age of immunotherapy: a 2023 update

A Bhatia, B Burtness - Drugs, 2023 - Springer
Most patients diagnosed with head and neck squamous cell carcinoma (HNSCC) will
present with locally advanced disease, requiring multimodality therapy. While this approach …

Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues

D Boda, AO Docea, D Calina… - International …, 2018 - spandidos-publications.com
Human papilloma viruses (HPV) are a small group of non‑enveloped viruses belonging to
the Papillomaviridae family with strong similarities to polyoma viruses. The viral particles …

Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations

AL Ho, I Brana, R Haddad, J Bauman… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE Mutations in the HRAS (m HRAS) proto-oncogene occur in 4%-8% of patients
with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) …

[HTML][HTML] Role of E2F transcription factor in oral cancer: Recent insight and advancements

A Kassab, I Gupta, AE Al Moustafa - Seminars in cancer biology, 2023 - Elsevier
The family of mammalian E2F transcription factors (E2Fs) comprise of 8 members (E2F1-
E2F8) classified as activators (E2F1-E2F3) and repressors (E2F4-E2F8) primarily regulating …

Epigenetic control of gene expression: Potential implications for cancer treatment

F Perri, F Longo, M Giuliano, F Sabbatino… - Critical reviews in …, 2017 - Elsevier
Epigenetic changes are defined as inherited modifications that are not present in DNA
sequence. Gene expression is regulated at various levels and not only in response to DNA …

Major molecular signaling pathways in oral cancer associated with therapeutic resistance

S Usman, A Jamal, MT Teh, A Waseem - Frontiers in Oral Health, 2021 - frontiersin.org
Oral cancer is a sub-category of head and neck cancers that primarily initiates in the oral
cavity. The primary treatment option for oral cancer remains surgery but it is associated with …

Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications

T Helsten, M Schwaederle, R Kurzrock - Cancer and Metastasis Reviews, 2015 - Springer
Fibroblast growth factors (FGFs) and their receptors (FGFRs) are transmembrane growth
factor receptors with wide tissue distribution. FGF/FGFR signaling is involved in neoplastic …

Molecular profiling of head and neck squamous cell carcinoma

R Feldman, Z Gatalica, J Knezetic, S Reddy… - Head & …, 2016 - Wiley Online Library
Background Head and neck squamous cell carcinoma (HNSCC) exhibits high rates of
recurrence, and with few approved targeted agents, novel treatments are needed. We …

Low-concentration PTX and RSL3 inhibits tumor cell growth synergistically by inducing ferroptosis in mutant p53 hypopharyngeal squamous carcinoma

J Ye, X Jiang, Z Dong, S Hu, M Xiao - Cancer Management and …, 2019 - Taylor & Francis
Introduction RSL3-induced ferroptosis is a cell death pathway dependent upon intracellular
iron and is characterized by accumulation of lipid hydroperoxides. Glutaminolysis, a …

Role of IQGAP1 in Carcinogenesis

T Wei, PF Lambert - Cancers, 2021 - mdpi.com
Simple Summary IQ motif-containing GTPase-activating protein 1 (IQGAP1) is a signal
scaffolding protein that regulates a range of cellular activities by facilitating signal …